Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JP Morgan Maintains Overweight on Allstate, Raises Price Target to $254

Author: Benzinga Newsdesk | October 09, 2025 08:47am
JP Morgan analyst Jimmy Bhullar maintains Allstate (NYSE:ALL) with a Overweight and raises the price target from $235 to $254.

Posted In: ALL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist